These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34738234)

  • 21. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J; Ohnesorge N; Rose-John S
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. sIL-6R: more than an agonist?
    Knüpfer H; Preiss R
    Immunol Cell Biol; 2008 Jan; 86(1):87-91. PubMed ID: 17724457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
    J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer.
    Garbers C; Spudy B; Aparicio-Siegmund S; Waetzig GH; Sommer J; Hölscher C; Rose-John S; Grötzinger J; Lorenzen I; Scheller J
    J Biol Chem; 2013 Feb; 288(6):4346-54. PubMed ID: 23209286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer.
    Taher MY; Davies DM; Maher J
    Biochem Soc Trans; 2018 Dec; 46(6):1449-1462. PubMed ID: 30467123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
    Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
    J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
    Esnault S; Khosravi M; Kelly EA; Liu LY; Bochkov YA; Tattersall MC; Jarjour NN
    Clin Exp Allergy; 2021 Apr; 51(4):564-573. PubMed ID: 33471392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6: A Masterplayer in the Cytokine Network.
    Uciechowski P; Dempke WCM
    Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and functional characterization of IL-6 receptor (IL-6R) and glycoprotein 130 (gp130) in Nile tilapia (Oreochromis niloticus).
    Zhou E; Yan F; Li B; Chen M; Tu X; Wu S; Wu H; Wei X; Fu S; Wu L; Guo Z; Ye J
    Dev Comp Immunol; 2020 May; 106():103629. PubMed ID: 31987875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
    Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
    Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
    Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of cilia-localized Il-6R alpha by 17beta-estradiol in mouse and human fallopian tubes.
    Shao R; Nutu M; Karlsson-Lindahl L; Benrick A; Weijdegård B; Lager S; Egecioglu E; Fernandez-Rodriguez J; Gemzell-Danielsson K; Ohlsson C; Jansson JO; Billig H
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C140-51. PubMed ID: 19420002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation.
    März P; Herget T; Lang E; Otten U; Rose-John S
    Eur J Neurosci; 1997 Dec; 9(12):2765-73. PubMed ID: 9517481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of IL-6 trans-signaling.
    Rose-John S
    Cytokine; 2021 Aug; 144():155577. PubMed ID: 34022535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities.
    Scheller J; Garbers C; Rose-John S
    Semin Immunol; 2014 Feb; 26(1):2-12. PubMed ID: 24325804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regenerative activity of interleukin-6.
    Galun E; Rose-John S
    Methods Mol Biol; 2013; 982():59-77. PubMed ID: 23456862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.